| Literature DB >> 25140205 |
Shahrnaz Parsania1, Mohammad Shabani2, Kasra Moazzami3, Moazamehosadat Razavinasab1, Mohammad Hassan Larizadeh4, Masoud Nazeri5, Majid Asadi-Shekaari2, Moein Kermani5.
Abstract
OBJECTIVES: Neurotoxicity of anticancer drugs complicates treatment of cancer patients. Vinblastine (VBL) is reported to induce motor and cognitive impairments in patients receiving chronic low-dose regimen.Entities:
Keywords: Anticancer; Learning and memory; Motor function; Vinblastine
Year: 2014 PMID: 25140205 PMCID: PMC4137941
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Figure 1Effect of Vinblastine (VBL) on muscle strength and coordination in grasping test (A) and rotarod test (B)., **P< 0.01, * P< 0.05 as compared with saline and male groups respectively. VBL did decrease muscle strength and time spent on rod compared with saline only in the male group. A significant difference was also observed between male and female groups. Values are expressed as mean±SEM (n=12 for each group)
Figure 2Vinblastine significantly reduced rearing frequency (A) and TDM (B). Female treated rats had significant differences in rearing frequency and TDM with male treated rats. There were no significant differences in time spent in perimeter (C), time spent in center (D), and velocity (E) among the four groups. ** P< 0.01, *** P< 0.001 as compared with the control group. * P< 0.05 as compared with the male group
Figure 3Hidden platform training in the Morris water maze acquisition after 5 weeks treatment with saline or vinblastine (VBL). VBL treated rats showed increased distance travelled (A) and time spent (B) to reach the hidden platform compared with the saline treated rats. There were no significant differences in swimming speed (C) and crossing numbers in the correct quadrant (F) in the probe test. In the probe test, the path length traveled (D) and percent swimming time (E) by VBL rats in the correct quadrant were significantly less than the saline groups. * P< 0.05,** P< 0.01, *** P< 0.001 as compared with the saline group
Figure 4Neurons from the cerebellar cortex and hippocampus 5 weeks after exposure to Vinblastin (VBL). Most neurons from the cerebellum (A), and the hippocampus (B) in saline-treated rats have normal morphology (arrows), but for the VBL-treated groups, several degenerated cells (arrowheads) can be seen with shrinkaged nuclei and dark cytoplasm
Effect of vinblastine (VBL) treatment on body weight and mortality rate of different groups of rats
| Body weight (g) | Mortality rate | |||||
|---|---|---|---|---|---|---|
| Group | aPND 23 | PND 30 | PND 37 | PND 45 | PND 52 | |
| bSaline M | 48.2±4.01 | 80.7±4.2 | 115.5±6.1 | 150.1±5.8 | 167.8±8.1 | 1 |
| cSaline F | 45.8±3.3 | 71.5±3.3 | 105.6±4.9 | 123.7±7.6 | 129±8.3 | 0 |
| d VBL M | 46.6±2.7 | 74.1±7.1 | 75.04±6.3** | 100.5±6.2** | 110.2±6.5*** | 3 |
| e VBL F | 48.1±5.3 | 70.5±6.6 | 96.8±8.1 | 97.9±4.5** | 105.9±5.1** | 2 |
No differences were observed in weight between saline and VBL groups on the 1st day of experimental procedure, while long-term exposure to VBL 0.2 mg/kg (the 2nd, 3rd, and 4th weeks) significantly decreased body weight in the male VBL group and in the 3rd and 4th weeks in female VBL rats. **, *** P< 0.01, P< 0.001, indicate statistically significant differences between male and female VBL treated rats compared with saline groups, respectively, (n=at least 12 rats in each group). a: Postnatal Day, b: Saline Male c: Saline Female, d: VBL Male and e: VBL Female